Citadel Advisors’s Qualigen Therapeutics QLGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,072
| Closed | -$26.2K | – | 6620 |
|
|
2024
Q3 | $26.2K | Buy |
+3,072
| New | +$26.2K | ﹤0.01% | 5281 |
|
|
2024
Q2 | – | Sell |
-1,144
| Closed | -$22.3K | – | 6645 |
|
|
2024
Q1 | $22.3K | Buy |
1,144
+448
| +64% | +$8.73K | ﹤0.01% | 5527 |
|
|
2023
Q4 | $19.1K | Buy |
+696
| New | +$19.1K | ﹤0.01% | 5387 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6581 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6548 |
|
|
2022
Q2 | – | Sell |
-249
| Closed | -$82K | – | 6742 |
|
|
2022
Q1 | $82K | Buy |
+249
| New | +$82K | ﹤0.01% | 5737 |
|
|
2021
Q4 | – | Sell |
-41
| Closed | -$26K | – | 7031 |
|
|
2021
Q3 | $26K | Sell |
41
-37
| -47% | -$23.5K | ﹤0.01% | 6257 |
|
|
2021
Q2 | $77K | Sell |
78
-374
| -83% | -$369K | ﹤0.01% | 6070 |
|
|
2021
Q1 | $610K | Buy |
452
+360
| +391% | +$486K | ﹤0.01% | 4397 |
|
|
2020
Q4 | $138K | Sell |
92
-15
| -14% | -$22.5K | ﹤0.01% | 4603 |
|
|
2020
Q3 | $266K | Buy |
107
+39
| +57% | +$97K | ﹤0.01% | 3921 |
|
|
2020
Q2 | $135K | Buy |
68
+64
| +1,600% | +$127K | ﹤0.01% | 4179 |
|
|
2020
Q1 | $14K | Buy |
+4
| New | +$14K | ﹤0.01% | 4702 |
|
|
2018
Q4 | – | Sell |
-1
| Closed | -$19K | – | 4856 |
|
|
2018
Q3 | $19K | Buy |
+1
| New | +$19K | ﹤0.01% | 4138 |
|
|
2018
Q1 | – | Sell |
-1
| Closed | -$37K | – | 4323 |
|
|
2017
Q4 | $37K | Buy |
+1
| New | +$37K | ﹤0.01% | 3687 |
|
|
2017
Q3 | – | Hold |
0
| – | -$6K | – | 4020 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 3589 |
|
|
2015
Q3 | – | Hold |
0
| – | -$85K | – | 4232 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 3316 |
|